High‐Throughput Heterospheroid‐Based Screening Identifies Drugs That Reprogram Tumor‐Associated Macrophages
Journal of Immunology Research · 2026-01 · 2026 (1)
DOI: 10.1155/jimr/2889509 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Immunology Research, online erschienen am 20.04.2026. Verfasst von Hiroyuki Tsuchiya und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Regenerative Medicine and Therapeutics, Department of Genomic Medicine and Regenerative Therapy, Faculty of Medicine, Tottori University,…. Hauptthemen laut MEDLINE: Tumor-Associated Macrophages, Liver Neoplasms, Antineoplastic Agents. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
The tumor microenvironment (TME) provides a niche for immune evasion and immunotherapy resistance, in part, by recruiting pro‐tumor M2‐like macrophages. In the present study, using heterospheroids consisting of cancer cells and macrophages, we identified TAM activators, which are compounds that reprogram M2‐like tumor‐associated macrophages (TAMs) toward the antitumor M1‐like phenotype. THP‐1‐ or human peripheral monocyte‐derived macrophages were co‐cultured with liver cancer (LC) cells in an ultra‐low attachment dish to generate heterospheroids. Cell surface marker expression and macrophage infiltration into the heterospheroids were assessed by flow cytometry and fluorescence microscopy, respectively. Lipopolysaccharide (LPS) and interferon‐γ (IFNγ)‐induced M1 marker expression was observed on the macrophages in the homospheroids; however, this induction was suppressed in heterospheroids. Microscopic imaging revealed that macrophage infiltration into the heterospheroids was decreased in the presence of LPS and IFNγ, which prompted us to develop a high‐content imaging screen. We identified two compounds [alprostadil (prostaglandin E1) and HX531] with TAM‐activating activity. RNA‐seq analysis revealed that HX531 modulated the immune and IFN response in cancer cells and cell division in macrophages. Moreover, alprostadil promoted the M1‐like polarization of TAMs, increased tumor‐infiltrating CD8 + T cells, and enhanced anti‐PD‐1 antibody therapeutic efficacy in a syngeneic tumor‐bearing mouse. In conclusion, the heterospheroid culture recapitulates the immunosuppressive TME, which prevents the M1 polarization of TAMs. It provides a new platform for screening TAM activators and will enable the development of novel cancer immunotherapeutics when combined with high‐content imaging analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Regenerative Medicine and Therapeutics, Department of Genomic Medicine and Regenerative Therapy, Faculty of Medicine, Tottori University, 86 Nishi-cho, Yonago, Tottori, 683-8503, Japan, tottori-u.ac.jp.
- Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, Faculty of Medicine, Tottori University, 86 Nishi-cho, Yonago, Tottori, 683-8503, Japan, tottori-u.ac.jp.
- Division of Medical Education, Department of Medical Education, Faculty of Medicine, Tottori University, 86 Nishi-cho, Yonago, Tottori, 683-8503, Japan, tottori-u.ac.jp.
ORCID-Profile: Hiroyuki Tsuchiya, Takehiko Hanaki, Daisuke Nanba
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Tsuchiya, H., Hanaki, T., Obora, M., Yoshida, J., Kishino, M., Fujiwara, Y., & Nanba, D. (2026). High‐Throughput Heterospheroid‐Based Screening Identifies Drugs That Reprogram Tumor‐Associated Macrophages. Journal of Immunology Research, 2026(1). https://doi.org/10.1155/jimr/2889509
Vancouver
Tsuchiya H, Hanaki T, Obora M, Yoshida J, Kishino M, Fujiwara Y, et al. High‐Throughput Heterospheroid‐Based Screening Identifies Drugs That Reprogram Tumor‐Associated Macrophages. Journal of Immunology Research. 2026;2026(1). doi:10.1155/jimr/2889509
BibTeX
@article{Tsuchiya2026,
author = {Tsuchiya, Hiroyuki and Hanaki, Takehiko and Obora, Mayu and Yoshida, Jun and Kishino, Mikiya and Fujiwara, Yoshiyuki and Nanba, Daisuke},
title = {High‐Throughput Heterospheroid‐Based Screening Identifies Drugs That Reprogram Tumor‐Associated Macrophages},
journal = {Journal of Immunology Research},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/jimr/2889509}
}
EUVIMED